Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This study involves the use of an investigational drug called NGP 555. In each group of
healthy subjects, 2 people will receive placebo and 6 people will receive NGP 555.